202 related articles for article (PubMed ID: 31430111)
1. Characterizing TDP-43
Laos V; Do TD; Bishop D; Jin Y; Marsh NM; Quon B; Fetters M; Cantrell KL; Buratto SK; Bowers MT
ACS Chem Neurosci; 2019 Sep; 10(9):4112-4123. PubMed ID: 31430111
[TBL] [Abstract][Full Text] [Related]
2. ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.
Lim L; Wei Y; Lu Y; Song J
PLoS Biol; 2016 Jan; 14(1):e1002338. PubMed ID: 26735904
[TBL] [Abstract][Full Text] [Related]
3. Catalytic Cross Talk between Key Peptide Fragments That Couple Alzheimer's Disease with Amyotrophic Lateral Sclerosis.
Laos V; Bishop D; Ganguly P; Schonfeld G; Trapp E; Cantrell KL; Buratto SK; Shea JE; Bowers MT
J Am Chem Soc; 2021 Mar; 143(9):3494-3502. PubMed ID: 33621087
[TBL] [Abstract][Full Text] [Related]
4. ALS-Linked A315T and A315E Mutations Enhance β-Barrel Formation of the TDP-43
Liu X; Li X; Qiao Q; Li F; Wei G
ACS Chem Neurosci; 2023 Apr; 14(7):1310-1320. PubMed ID: 36888995
[TBL] [Abstract][Full Text] [Related]
5. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
[TBL] [Abstract][Full Text] [Related]
6. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
[TBL] [Abstract][Full Text] [Related]
7. ALS-associated A315E and A315pT variants exhibit distinct mechanisms in inducing irreversible aggregation of TDP-43
Liu X; Lao Z; Li X; Dong X; Wei G
Phys Chem Chem Phys; 2022 Jul; 24(26):16263-16273. PubMed ID: 35758309
[TBL] [Abstract][Full Text] [Related]
8. The amyloidogenicity of a C-terminal region of TDP-43 implicated in Amyotrophic Lateral Sclerosis can be affected by anions, acetylation and homodimerization.
Prasad A; Sivalingam V; Bharathi V; Girdhar A; Patel BK
Biochimie; 2018 Jul; 150():76-87. PubMed ID: 29751083
[TBL] [Abstract][Full Text] [Related]
9. Modulating ALS-Related Amyloidogenic TDP-43
Laos V; Bishop D; Lang CA; Marsh NM; Cantrell KL; Buratto SK; Singh AK; Bowers MT
Biochemistry; 2020 Feb; 59(4):499-508. PubMed ID: 31846303
[TBL] [Abstract][Full Text] [Related]
10. Atomistic Insights into A315E Mutation-Enhanced Pathogenicity of TDP-43 Core Fibrils.
Li F; Chen Y; Liu X; Tang Y; Dong X; Wei G
ACS Chem Neurosci; 2022 Sep; 13(18):2743-2754. PubMed ID: 36053560
[TBL] [Abstract][Full Text] [Related]
11. Computationally Designed Molecules Modulate ALS-Related Amyloidogenic TDP-43
Liu X; Duan S; Jin Y; Walker E; Tsao M; Jang JH; Chen Z; Singh AK; Cantrell KL; Ingolfsson HI; Buratto SK; Bowers MT
ACS Chem Neurosci; 2023 Dec; 14(24):4395-4408. PubMed ID: 38050862
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the effect of ALS mutation S375G on the conformational properties and aggregation dynamics of TDP-43
Xu Z; Zhang J; Tang J; Gong Y; Zou Y; Zhang Q
Biophys Chem; 2024 Jul; 310():107230. PubMed ID: 38615537
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Full-Length TDP-43 Oligomers Retain Their Ability to Bind RNAs, Are Not Toxic, and Do Not Seed TDP-43 Aggregation in Vitro.
Yang L; Jasiqi Y; Lashuel H
ACS Chem Neurosci; 2024 Jan; 15(1):193-204. PubMed ID: 38116987
[TBL] [Abstract][Full Text] [Related]
14. Characterization of β-domains in C-terminal fragments of TDP-43 by scanning tunneling microscopy.
Xu M; Zhu L; Liu J; Yang Y; Wu JY; Wang C
J Struct Biol; 2013 Jan; 181(1):11-6. PubMed ID: 23138004
[TBL] [Abstract][Full Text] [Related]
15. Activation of ER Stress and Autophagy Induced by TDP-43 A315T as Pathogenic Mechanism and the Corresponding Histological Changes in Skin as Potential Biomarker for ALS with the Mutation.
Wang X; Zhou S; Ding X; Ma M; Zhang J; Zhou Y; Wu E; Teng J
Int J Biol Sci; 2015; 11(10):1140-9. PubMed ID: 26327808
[TBL] [Abstract][Full Text] [Related]
16. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
17. Induction of amyloid fibrils by the C-terminal fragments of TDP-43 in amyotrophic lateral sclerosis.
Chen AK; Lin RY; Hsieh EZ; Tu PH; Chen RP; Liao TY; Chen W; Wang CH; Huang JJ
J Am Chem Soc; 2010 Feb; 132(4):1186-7. PubMed ID: 20055380
[TBL] [Abstract][Full Text] [Related]
18. An acridine derivative, [4,5-bis{(N-carboxy methyl imidazolium)methyl}acridine] dibromide, shows anti-TDP-43 aggregation effect in ALS disease models.
Prasad A; Raju G; Sivalingam V; Girdhar A; Verma M; Vats A; Taneja V; Prabusankar G; Patel BK
Sci Rep; 2016 Dec; 6():39490. PubMed ID: 28000730
[TBL] [Abstract][Full Text] [Related]
19. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation.
Tanaka Y; Nonaka T; Suzuki G; Kametani F; Hasegawa M
Hum Mol Genet; 2016 Apr; 25(7):1420-33. PubMed ID: 26908597
[TBL] [Abstract][Full Text] [Related]
20. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
